TGen News & Press Releases

TGen appoints J. Gregory Caporaso, Ph.D., Professor in its Pathogen and Microbiome Division

Posted Tuesday July 25, 2023

Erroneous genetic sequences identified for the first time in specific cells of ALS and frontotemporal dementia patients

Posted Wednesday July 19, 2023

Gene splicing defect known as “cryptic exons” detected using single-nuclei RNA sequencing

Novel Genetic Sequencing Technology Helps Researchers Find Answers in Cases of Pediatric Rare Disorders

Posted Monday July 10, 2023

The study identified likely cause of genetic disorder in six families

Single-Cell Atlas of the Whole Human Lung

Posted Thursday June 8, 2023

First integrated Human Lung Cell Atlas provides insights into lung diseases

ATLANTA NON-PROFIT, PURPLE PANSIES, DONATES $726,000 IN SUPPORT OF TGEN CLINICAL STUDY

Posted Tuesday May 23, 2023

TGen recognizes Valley leader, William Post, and Atlanta restauranteur, Maria Fundora, at its annual Founders Dinner

Posted Tuesday May 2, 2023

Awards recognize sustained commitment to furthering research and precision medicine

Genomic sequencing shows promise in preparation for emerging disease outbreaks

Posted Monday May 1, 2023

TGen scientists test new NGS technologies for utility in large-scale pandemic responses

TGen-led study tracks infection and immunity across the universe of human viruses over time

Posted Monday April 3, 2023

Results offer glimpse into the future of forecasting infection and immunity

Researchers detail changes in the blood-brain barrier related to Alzheimer’s disease

Posted Friday February 24, 2023

The brain tissue grows and accumulates abnormal inflammatory signals

Runway for Research Final Totals Over $231,000

Posted Wednesday January 25, 2023

TGen fashion show fundraiser achieves record amount, announces 2023 co-chairs and date

Prev
1
2
[3]
4
5
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive

2024 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445